← Back to Search

Behavioural Intervention

DepWatch for Depression (DepWatch Trial)

N/A

Recruiting

Led By Jayesh Kamath, MD PhD

Research Sponsored by UConn Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 years or older

Moderate level of depression as defined by a score of ≥ 11 on the 16 item Quick Inventory of Depressive Symptomatology (QIDS) self-report questionnaire

Must not have

Diagnosis of a primary psychotic disorder such as schizophrenia or schizoaffective disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 surveys conducted 4 months apart (over the 12 month study period)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to develop and test a new digital system called DepWatch that uses mobile health technologies and machine learning to help clinicians monitor and adjust depression treatment. The system collects data from smartphones and wristbands

Who is the study for?

This trial is for adults 18 years or older with moderate depression, starting new medication or increasing the dose of their current one. Participants must score ≥11 on a specific depression questionnaire (QIDS).

What is being tested?

The study tests 'DepWatch', an mHealth tool that tracks and predicts depression symptoms using data from smartphones and wristbands to help doctors make better treatment decisions.

What are the potential side effects?

Since DepWatch involves monitoring via mobile devices, side effects are not typical as with medications; however, participants may experience privacy concerns or stress related to constant data collection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have moderate depression based on a specific questionnaire score.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with a psychotic disorder like schizophrenia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 surveys conducted 4 months apart (over the 12 month study period)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 surveys conducted 4 months apart (over the 12 month study period)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 surveys conducted 4 months apart (over the 12 month study period) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Feasibility and Usability

Secondary study objectives

Depression outcomes

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: ExperimentalExperimental Treatment1 Intervention

For this group of participants: The study clinicians will receive the weekly depression and behavioral assessment reports generated by the mHealth tool 'DepWatch' via a secure clinician portal

Group II: ControlExperimental Treatment1 Intervention

For this group of participants: The study clinicians will NOT receive the weekly depression and behavioral assessment reports generated by the mHealth tool 'DepWatch'

0 / 3Eligibility criteria met